Development and Use of Non-FDG PET Radiopharmaceuticals at the Masaryk Memorial Cancer Institute


Klin Onkol 2012; 25(Suppl 2): 82-86. DOI: 10.14735/amko20122S82.

The existence of the cyclotron & PET centre of ÚJV Řež, a.s., at Masaryk Memorial Cancer Institute allows the Masaryk Memorial Cancer Institute and RECAMO researchers to engage in the research, development and application of new radiopharmaceuticals including compounds labelled by short-living positron emitters (especially [11C]). Currently, a [11C]-labelled tracer, L-[methyl-11C]methionine, is entering phase I clinical evaluation, and scans with PET radiopharmaceuticals other than fluorodeoxyglucose are performed at the Department of Nuclear Medicine. Continued cooperation will bring new possibilities for PET in the Czech Republic in the future.

Full text in PDF